Intrinsic Value of S&P & Nasdaq Contact Us

aTyr Pharma, Inc. ATYR NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.13
+510.1%

Stock Statistics — ATYR

aTyr Pharma, Inc. (ATYR) has a market capitalization of $82.45M and trades at $0.84. The 52-week range is 0.64-7.29.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-0.80, annual revenue of $190K.

The stock has a beta of 0.65, operates in the Healthcare sector.

Trading Data
Current Price$0.84
52-Week Range0.64-7.29
Volume653.22K
Avg Volume (30D)1.65M
Market Cap$82.45M
Beta (1Y)0.65
Company
IPO Date2015-05-07
Employees56
CEOSanjay S. Shukla
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS0021202025
CUSIP002120202
Income (Latest Year)
Revenue$190K
Gross Profit$-1.36M
EBITDA$-76.07M
Operating Income$-77.63M
Net Income$-74.12M
EPS$-0.80
EPS Diluted$-0.80
Shares Outstanding$92.99M
Balance Sheet (Latest Year)
Total Assets$94.16M
Current Assets$80.24M
Cash & ST Investments$78.69M
Total Liabilities$26.88M
Total Debt$12.03M
Net Debt$1.29M
Total Equity$67.29M
Debt / Equity0.18
Valuation Ratios
P/E Ratio-1.1
P/S Ratio433.95
P/B Ratio1.23
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message